Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02136199
Other study ID # 14-002055
Secondary ID
Status Completed
Phase N/A
First received March 24, 2014
Last updated May 23, 2016
Start date September 2014
Est. completion date May 2016

Study information

Verified date May 2016
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The active strategy for dissemination and implementation of Share Evidence Based Medicine (EBM) will yield greater reach of clinicians, be adopted by the practices more readily, and a greater uptake of use amongst encounters will be seen.

The Institute for Clinical Systems Improvement (ICSI) is a nonprofit organization with expertise in large-scale practice improvement at the state and national level. Largely funded by health organizations in Minnesota, ICSI has a sustainable model to translate evidence into practice, through clinical practice guidelines, shared decision making, and practice redesign. A partnership between these two organizations (ICSI and Mayo Clinic) may lead to a sustainable and innovative approach to the dissemination of evidence-based health information at the point of care.

The objective of the current study is therefore to leverage the expertise of these two organizations to compare the impact of an active to a passive dissemination and implementation strategy of the ShareEBM toolkit. The aim of the study is to disseminate evidence-based information through the use of decision aids during encounters. The overall purpose of the qualitative evaluation is to understand why decision aids were used more or less in certain practices and what factors contributed to or hindered this uptake.


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date May 2016
Est. primary completion date May 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Practices meeting the following criteria will be deemed eligible for the study if they have:

1. At least 2 primary care clinicians committed to participate in the study. Clinicians are defined as any healthcare professional providing patient care (i.e., physicians, nurse practitioners, physician assistants, diabetes educators)

2. A designated site champion and support staff that can provide the support needed to conduct the study

3. An IRB approval from their institution or are covered under Mayo Clinic IRB

4. Leadership is committed to this research and has endorsed the study

- Any clinician caring for patients with a chronic condition and who has opportunities to discuss medication management with their patients will be deemed eligible

Exclusion Criteria:

- Major barriers to participating or to providing informed consent

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Other:
Active Implementation of ShareEBM Toolkit

Passive Dissemination of Share EBM


Locations

Country Name City State
United States Baldwin Area Medical Center, Inc. Baldwin Wisconsin
United States Park Nicollet- Brookdale Brooklyn Center Minnesota
United States Ridgeview Medical Center Delano Minnesota
United States Essentia Health-Lakeside Clinic Duluth Minnesota
United States Fairview Clinic-Eagan Eagan Minnesota
United States Park Nicollet-Golden Valley Golden Valley Minnesota
United States Essentia Hermantown Clinic Hermantown Minnesota
United States Hudson Physicians S.C. Hudson Wisconsin
United States Native American Community Clinic Minneapolis Minnesota
United States Community Health Service, Inc. Rochester Minnesota
United States Mayo Clinic Rochester Minnesota
United States Fairview Medical-Rosemount Rosemount Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency of use of decision aids in clinical encounters by weekly reports up to 1 year No